Charged-particle therapy for hepatocellular carcinoma

Area of Science:

• Radiation Oncology
• Hepatocellular Carcinoma Research
• Medical Physics

Background:

• External-beam radiotherapy for hepatocellular carcinoma (HCC) historically faced limitations due to toxicity in surrounding liver tissue.
• Photon radiotherapy advancements improved dose conformity but still delivered low doses to large liver volumes, hindering dose escalation.
• Limited functional liver reserves in some patients restrict aggressive radiotherapy approaches.

Purpose of the Study:

• To review the biophysical attributes of proton and carbon ion radiotherapy for HCC.
• To discuss the clinical outcomes and toxicity associated with charged-particle therapy in HCC treatment.
• To explore the potential of charged-particle therapy for dose escalation without excessive liver toxicity.

Main Methods:

• Review of existing literature on proton and carbon ion radiotherapy for hepatocellular carcinoma.
• Analysis of the distinctive biophysical properties of charged-particle beams.
• Evaluation of clinical outcomes and toxicity data from charged-particle therapy studies in HCC.

Main Results:

• Charged-particle therapy leverages unique properties like lack of exit dose and higher biological effectiveness.
• This modality offers potential for dose escalation to maximize tumor control in HCC.
• Early findings suggest reduced toxicity to uninvolved liver compared to traditional photon radiotherapy.

Conclusions:

• Charged-particle therapy, specifically proton and carbon ion radiotherapy, presents a promising advancement for hepatocellular carcinoma treatment.
• The ability to escalate radiation doses while sparing healthy liver tissue is a key advantage.
• Further research and clinical data are essential to fully establish the role of charged-particle therapy in HCC management.